Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism A1R antagonists(Adenosine A1 receptor antagonists), A2aR antagonists(Adenosine A2a receptor antagonists), H3 receptor antagonists(Histamine H3 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC24H26N4O |
InChIKeyBDUVGZUKNGPFEZ-UHFFFAOYSA-N |
CAS Registry2747057-95-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Parkinson Disease | Preclinical | DE | 24 Jun 2021 |